Expression of angiogenic factors in hepatocellular carcinoma after transcatheter arterial chemoembolization

被引:0
|
作者
Liao Xiaofeng
Yi Jilin
Li Xingrui
Yang Zhifang
Deng Wei
Tian Geng
机构
[1] Huazhong University of Science and Technology,Department of General Surgery, Tongji Hospital, Tongji Medical College
关键词
hepatocellular carcinoma; chemoembolization; vascular endothelial growth factor; basic fibroblast growth factor;
D O I
10.1007/BF02829514
中图分类号
学科分类号
摘要
In order to investigate the changes of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in residual hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE), the expression levels of VEGF and bFGF expression in specimens surgically removed from 48 HCC patients were detected by immunohistochemical methods, and staining intensity of VEGF and bFGF was assessed by a computer-assisted image-analyzer. Among the 48 patients, 25 underwent partial hepatectomy alone (single operating group), and 23 were subjected to second stage surgical resection after TACE (TACE group). The results showed that the average absorbance value (A) of VEGF was higher in TACE group than that in single operating group (0.152±0.021 vs 0.131±0.012,P<0.01). The Average A of bFGF in TACE group was 0.127±0.023, higher than in single operating group (0.111±0.016,P<0.05). These results suggested that TACE of HCC can up-regulate the expression of VEGF and bFGF in HCC tissues possibly due to anoxia and ischemia.
引用
收藏
页码:280 / 282
页数:2
相关论文
共 50 条
  • [41] Incidence of acute hepatic failure and related risk factors after transcatheter arterial chemoembolization of hepatocellular carcinoma
    Park, Kyungsik
    Jang, Byoungkuk
    Chung, Woojin
    Cho, Kwangbum
    Hwang, Jaeseok
    Ahn, Sunghoon
    Kim, Younghwan
    Choi, Jinsu
    Hwang, Junyoung
    GASTROENTEROLOGY, 2006, 130 (04) : A498 - A498
  • [42] Risk factors for the leakage of chemotherapeutic agents into systemic circulation after transcatheter arterial chemoembolization of hepatocellular carcinoma
    Hsieh, Ming-Yen
    Lin, Zu-Yau
    Chen, Su-Hwei
    Chuang, Wan-Long
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2011, 27 (10): : 431 - 436
  • [43] INCIDENCE AND RISK FACTORS OF CONTRAST-INDUCED NEPHROPATHY AFTER TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION IN HEPATOCELLULAR CARCINOMA
    Aoe, Mari
    Kanemitsu, Takafumi
    Ohki, Takamasa
    Ambe, Hiroko
    Furukawa, Emi
    Kurata, Yu
    Ichikawa, Masahiro
    Ohara, Ken
    Honda, Tomoko
    Furuse, Satoshi
    Saito, Katsunori
    Toda, Nobuo
    Mise, Naobumi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 408 - 409
  • [44] Incidence and risk factors of contrast-induced nephropathy after transcatheter arterial chemoembolization in hepatocellular carcinoma
    Mari Aoe
    Takafumi Kanemitsu
    Takamasa Ohki
    Satoru Kishi
    Yoshiyasu Ogura
    Yuto Takenaka
    Toyohiro Hashiba
    Hiroko Ambe
    Emi Furukawa
    Yu Kurata
    Masahiro Ichikawa
    Ken Ohara
    Tomoko Honda
    Satoshi Furuse
    Katsunori Saito
    Nobuo Toda
    Naobumi Mise
    Clinical and Experimental Nephrology, 2019, 23 : 1141 - 1146
  • [45] Transcatheter arterial chemoembolization of hepatocellular carcinoma: A Japanese experience
    Higashihara, H
    Okazaki, M
    HEPATO-GASTROENTEROLOGY, 2002, 49 (43) : 72 - 78
  • [46] Transcatheter arterial chemoembolization (TACE) in treatment of hepatocellular carcinoma
    Barone, M
    Ettorre, GC
    Ladisa, R
    Schiavariello, M
    Santoro, C
    Francioso, G
    Vinciguerra, V
    Francavilla, A
    HEPATO-GASTROENTEROLOGY, 2003, 50 (49) : 183 - 187
  • [47] Nonresectable Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Analysis of the Response and Prognostic Factors after Transcatheter Arterial Chemoembolization
    Kim, Jin Hyoung
    Yoon, Hyun-Ki
    Ko, Gi-Young
    Gwon, Dong Il
    Jang, Cheol Soo
    Song, Ho-Young
    Shin, Ji Hoon
    Sung, Kyu-Bo
    RADIOLOGY, 2010, 255 (01) : 270 - 277
  • [48] Shrinkage of hepatocellular carcinoma after radiofrequency ablation following transcatheter arterial chemoembolization: Analysis of contributing factors
    Yu, Mi Hye
    Kim, Young Jun
    Park, Hee Sun
    Jung, Sung Il
    Jeon, Hae Jeong
    PLOS ONE, 2019, 14 (02):
  • [49] Incidence and risk factors of contrast-induced nephropathy after transcatheter arterial chemoembolization in hepatocellular carcinoma
    Aoe, Mari
    Kanemitsu, Takafumi
    Ohki, Takamasa
    Kishi, Satoru
    Ogura, Yoshiyasu
    Takenaka, Yuto
    Hashiba, Toyohiro
    Ambe, Hiroko
    Furukawa, Emi
    Kurata, Yu
    Ichikawa, Masahiro
    Ohara, Ken
    Honda, Tomoko
    Furuse, Satoshi
    Saito, Katsunori
    Toda, Nobuo
    Mise, Naobumi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (09) : 1141 - 1146
  • [50] ASPP2 expression predicts the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization
    Mao, Jiaren
    Tan, Zhongjun
    Pan, Xiaoqi
    Meng, Feijian
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (04)